Skip to main content
. 2022 Mar 1;14:100228. doi: 10.1016/j.mtbio.2022.100228

Table 2.

Different imaging approach with cell membrane.

Imaging approach Cell membrane Core Reference
FL RBCM FA and Cy5-modified nanoscale vesicles [35]
RBCM ICG [36]
MM Upconversion NPs [48]
PLM W18O49 NPs and metformin [51]
PLM Antibody-drug and scFvGPIIb/IIIa-monomethyl auristatin E [53]
Cancer-macrophage hybrid membrane IR825/Ir ZGGO@SiO2 [58]
PA CCM Dendritic mesoporous silica NPs-DNA probe [43]
PLM IR 1048 dye-loaded liposomes [49]
Erythrocyte-cancer hybrid membrane Melanin NPs [60]
MRI RBCM Fe3O4 magnetic NPs [37]
RBCM Cyp-superparamagnetic nanoclusters [39]
CCM Mesoporous copper/manganese silicate nanospheres [44]
SCM Fe3O4@PDA-siRNA NPs [54]
PTT Bacterial-cancer hybrid membrane HPDA@[OMV-CC] NPs [59]
CT MM Quercetin-loaded hollow Bi2Se3 [47]
BM Magnetosomes [56]
PA/FL/PTT RBCM DOX-loaded Prussian blue nano-composites [38]
FL/MRI/PET CCM Upconversion NPs [41]
PA/PTT CCM Ir–B–TiO2 [42]
MRI/FL CCM Styrene and acrylic acid-crosslinked SPION [45]
FL/MRI/CT SCM Mn2+ and Gd3+ co-doped CuInS2–ZnS nanocrystals [55]
PA/FL PLM Dox-PFP-CNs@PLGA/PM NPs [50]
HHS Vulnerability Disclosure